Accumulating evidence shows the role of endogenous hydrogen sulfide (H
2S) in various disease, whereas its role of H
2S in intestinal inflammation. In addition, recent reports showed that H
2S modulates NF-kB signaling in macrophages, suggesting that H
2S could affect macrophage function. In this study, we studied the role of endogenous H
2S in a dextran sodium sulfate (DSS)-induced colitis model, particularly in relation to macrophage function.
Methods
Mice were treated with 8% DSS to induce colitis. DL-propargylglycine (PAG), an irreversible CSE (cystathionine gamma-lyase) inhibitor, and sodium sulfide (Na2S), an H2S donor, were administered intraperitoneally. The respective degrees of mucosal injury were evaluated macroscopically, histologically, and biochemistry. The effect of endogenous H2S on macrophage function was evaluated using bone-marrow derived macrophages (BMDMs).
Results
CSE and CBS (cystathionine beta-synthase) expressions in the colonic mucosa were increased in DSS-treated mice. PAG enhanced DSS-induced colonic damage and myeloperoxidase activity. Meanwhile, Na2S counteracted these effects of PAG. Furthermore, PAG-treated BMDMs manifested pro-inflammatory (M1), but not anti-inflammatory (M2) macrophages markers.
Conclusion
Our results demonstrated that endogenous H2S inhibited the development of intestinal inflammation through the regulation of macrophage function. In conclusion, H2S may be a novel therapeutic molecule in intestinal inflammation.